AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
AKR7A2 | Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | Enzymes Plasma proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
ALAS1 | Aminolevulinate, delta-, synthase 1 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ALDH18A1 | Aldehyde dehydrogenase 18 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ALKBH2 | AlkB, alkylation repair homolog 2 (E. coli) | Enzymes
| | | | | Expressed in all |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
ALX1 | ALX homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ALYREF | Aly/REF export factor | Plasma proteins
| | | | | Expressed in all |
AMPD2 | Adenosine monophosphate deaminase 2 | Enzymes
| | | | | Expressed in all |
AMPD3 | Adenosine monophosphate deaminase 3 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
ANAPC2 | Anaphase promoting complex subunit 2 | | | | | | Expressed in all |
ANKRD11 | Ankyrin repeat domain 11 | Disease related genes
| | | | | Expressed in all |
ANKRD13A | Ankyrin repeat domain 13A | | | | | | Expressed in all |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | | | | | | Group enriched |
ANLN | Anillin, actin binding protein | | | | | | Tissue enhanced |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Expressed in all |
ANXA11 | Annexin A11 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
ANXA3 | Annexin A3 | Plasma proteins
| | | | | Expressed in all |
ANXA5 | Annexin A5 | Disease related genes Plasma proteins
| | | | | Expressed in all |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
AP1G1 | Adaptor-related protein complex 1, gamma 1 subunit | | | | | | Expressed in all |
AP2A1 | Adaptor-related protein complex 2, alpha 1 subunit | | | | | | Expressed in all |
AP2A2 | Adaptor-related protein complex 2, alpha 2 subunit | Plasma proteins
| | | | | Expressed in all |
AP2B1 | Adaptor-related protein complex 2, beta 1 subunit | Cancer-related genes
| | | | | Expressed in all |
AP5Z1 | Adaptor-related protein complex 5, zeta 1 subunit | Disease related genes
| | | | | Expressed in all |
APEH | Acylaminoacyl-peptide hydrolase | Enzymes Plasma proteins
| | | | | Expressed in all |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
API5 | Apoptosis inhibitor 5 | | | | | | Expressed in all |
APTX | Aprataxin | Disease related genes
| | | | | Expressed in all |
ARFGAP2 | ADP-ribosylation factor GTPase activating protein 2 | | | | | | Expressed in all |
ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited) | | | | | | Expressed in all |
ARFIP1 | ADP-ribosylation factor interacting protein 1 | | | | | | Expressed in all |
ARFRP1 | ADP-ribosylation factor related protein 1 | | | | | | Expressed in all |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins
| | | | | Group enriched |
ARHGAP28 | Rho GTPase activating protein 28 | | | | | | Tissue enhanced |
ARHGAP4 | Rho GTPase activating protein 4 | | | | | | Expressed in all |
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 | Plasma proteins
| | | | | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ARID3B | AT rich interactive domain 3B (BRIGHT-like) | Transcription factors
| | | | | Mixed |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ASB9 | Ankyrin repeat and SOCS box containing 9 | | | | | | Tissue enhanced |
ASCC3 | Activating signal cointegrator 1 complex subunit 3 | Enzymes
| | | | | Expressed in all |
ASH1L | Ash1 (absent, small, or homeotic)-like (Drosophila) | Enzymes
| | | | | Expressed in all |
ASMTL | Acetylserotonin O-methyltransferase-like | | | | | | Expressed in all |